Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Akamara Biomedicine Private Limited, is an unlisted private company incorporated on 30 August, 2017. It is classified as a private limited company and is located in East Delhi, Delhi. It's authorized share capital is INR 1.00 lac and the total paid-up capital is INR 1.00 lac.
The current status of Akamara Biomedicine Private Limited is - Active.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2024 numbers.
9.29%
7.69%
-68.97%
2.15%
6.23%
5.07%
5.57
-0.31
-8.37
-8.01
-0.76
0.01
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(1)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Raghunath Anant Mashelkar | 00074119 | 7 years |
| Director | Shrikant Mantri | 01240147 | 3 years |
| Director | Shiladitya Sengupta | 01837274 | 7 years |
| Director | Rajeev Mantri | 01895901 | 3 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| GHARDA SCIENTIFIC RESEARCH FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
| INVICTUS ONCOLOGY PRIVATE LIMITED |
Active
|
2.1 Cr | 3 | Delhi |
| GHARDA MEDICAL & ADVANCED TECHNOLOGIES FOUNDATION |
Active
|
0.0 | 1 | Maharashtra |
| INTERNATIONAL LONGEVITY CENTRE- INDIA |
Active
|
0.0 | 1 | Maharashtra |
| SENTIENT LABS PRIVATE LIMITED |
Active
|
10.0 Cr | 1 | Maharashtra |
| DISOM FOUNDATION |
Active
|
10,000.0 | 1 | Maharashtra |
| VYOME THERAPEUTICS LIMITED |
Active
|
1.0 L | 2 | Gujarat |
| SAKAL MEDIA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| GPSK COMMODITIES PRIVATE LIMITED |
Active
|
84.4 L | 2 | West Bengal |
| NAVAM CAPITAL PRIVATE LIMITED |
Active
|
9.6 Cr | 2 | West Bengal |
| MANTRI HOLDINGS LTD. |
Active
|
27.0 L | 2 | West Bengal |
| GPSK CAPITAL PRIVATE LIMITED |
Active
|
13.3 Cr | 2 | West Bengal |
| SEMCO FINANCE PVT LTD. |
Amalgamated
|
2.0 Cr | 1 | West Bengal |
| RONALDSHAY ESTATE PRIVATE LIMITED |
Amalgamated
|
3,000.0 | 1 | West Bengal |
| EVERYDAY COMMODITIES PVT.LTD. |
Amalgamated
|
1.0 Cr | 1 | West Bengal |
| MANTRI ENTERPRISES PVT LTD |
Active
|
1.8 Cr | 2 | West Bengal |
| GOVIND NIKET PVT LTD |
Active
|
3.0 Cr | 2 | West Bengal |
| IEC RESEARCH FOUNDATION |
Active
|
10,000.0 | 2 | West Bengal |
| NAVAM TECHNOLOGY VENTURES LLP |
Active
|
30.0 L | 2 | Bengal |
| MANTRI HOLDINGS LLP |
Active
|
77.0 L | 2 | Bengal |
| SIL INVESTMENTS LIMITED |
Active
|
10.6 Cr | 1 | Rajasthan |
| NEW INDIA RETAILING & INVESTMENT LIMITED |
Active
|
11.6 Cr | 1 | West Bengal |
| VYOME BIOSCIENCES PRIVATE LIMITED |
Active
|
33.5 L | 2 | Gujarat |
| INDIA INNOVATION RESEARCH CENTER |
Active
|
0.0 | 1 | Karnataka |
| MITRA LIFE SCIENCES INDIA PRIVATE LIMITED |
Strike Off
|
5.0 L | 1 | Karnataka |
| Navam Frontier Tech Ventures LLP |
Active
|
4.6 Cr | 1 | Bengal |
| NAVAM INVESTMENT ADVISORS LLP |
Active
|
20,000.0 | 1 | Bengal |
The incorporation date of AKAMARA BIOMEDICINE PRIVATE LIMITED is 30 August, 2017
The authorized share capital of AKAMARA BIOMEDICINE PRIVATE LIMITED is INR ₹ 1.0 L.
The paid-up capital of AKAMARA BIOMEDICINE PRIVATE LIMITED is INR ₹ 1.0 L.
The registered address of AKAMARA BIOMEDICINE PRIVATE LIMITED is Plot No. 465, First Floor F.I.E. Patparganj Industrial Area Delhi East Delhi Delhi - 110092
The CIN number of AKAMARA BIOMEDICINE PRIVATE LIMITED is U73100DL2017PTC322917.
Expand
Delete
Collapse
See
details
